Proton magnetic resonance spectroscopy findings and clinical effects of montelukast sodium in a case with Sjogren-Larsson syndrome

Basit Öğe Kaydı
dc.contributor.authorPirgon, Ozgur
dc.contributor.authorAydin, Kursad
dc.contributor.authorAtabek, M. Emre
dc.date.accessioned2020-03-26T17:04:05Z
dc.date.available2020-03-26T17:04:05Z
dc.date.issued2006
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractSjogren-Larsson syndrome is a rare hereditary metabolic disorder characterized by congenital ichthyosis, mental retardation, and spastic diplegia or tetraplegia. This genetic disease is caused by fatty acid aldehyde dehydrogenase deficiency, leading to an accumulation of long-chain alcohols. The role of enzyme in the degradation of leukotrienes paved the way to the development of a new therapeutic strategy for Sjogren-Larsson syndrome, leukotriene antagonists. We describe a 3-year-old boy with Sjogren-Larsson syndrome who had a lipid peak on proton magnetic resonance spectroscopy despite normal findings on cerebral magnetic resonance imaging. He benefited from treatment with montelukast sodium, especially with respect to the agonizing pruritus.en_US
dc.identifier.doi10.1177/7010.2006.00300en_US
dc.identifier.endpage1095en_US
dc.identifier.issn0883-0738en_US
dc.identifier.issn1708-8283en_US
dc.identifier.issue12en_US
dc.identifier.pmid17156709en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1092en_US
dc.identifier.urihttps://dx.doi.org/10.1177/7010.2006.00300
dc.identifier.urihttps://hdl.handle.net/20.500.12395/20627
dc.identifier.volume21en_US
dc.identifier.wosWOS:000243207000021en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSAGE PUBLICATIONS INCen_US
dc.relation.ispartofJOURNAL OF CHILD NEUROLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleProton magnetic resonance spectroscopy findings and clinical effects of montelukast sodium in a case with Sjogren-Larsson syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu